Current and future commitment to hematology research

Hematology/Oncology Clinics of North America

Volumn 18, Issue 6 SPEC.ISS., 2004, Pages 1215-1234

  Peterson, Charles M ^a   Harvath, Liana ^a  

^a Division of Lung Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; HEMOGLOBIN F; PEGINTERFERON; RIBAVIRIN;

ADOPTIVE IMMUNOTHERAPY; ALLOIMMUNIZATION; BLOOD GROUP ABO SYSTEM; CREUTZFELDT JAKOB DISEASE; ERYTHROCYTE DISORDER; GENE CONTROL; GENE SILENCING; GENE THERAPY; GENE TRANSFER; GENERAL PRACTITIONER; HEART DISEASE; HEMATOLOGIC DISEASE; HEMATOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HEPATITIS C; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IRON CHELATION; MEDICAL RESEARCH; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SICKLE CELL ANEMIA; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THALASSEMIA MAJOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSACTIVATION; VASCULARIZATION;

EID: 7044229685     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2004.07.002     Document Type: Review

References (5)

1. History of the NIH Available at http://www.training.nih.gov/clinical/ nihhistory.asp Accessed September 16, 2004
2. L.E. Silberstein, and P. Toy Research opportunities in transfusion medicine JAMA 285 5 2001 577 580
3. J. McCulough Transfusion medicine: discipline with a future Transfusion 43 2003 823 828
4. E.J. Read, and M.T. Sullivan Cellular therapy services provided by blood centers and hospitals in the United States, 1999: an analysis from the Nationwide Blood Collection and Utilization Survey Transfusion 44 2004 539 546
5. D. Stroncek, L. Harvath, and J. Barrett National Heart, Lung, and Blood Institute of the National Institutes of Health Forum on Immune Reconstitution and Cellular Therapy Following Hematopoietic Stem-Cell Transplantation Cytotherapy 4 2002 415 418